Neurotech International Limited (ASX:NTI)
Australia · Delayed Price · Currency is AUD 0.0130
-0.0010 (-7.14%)
Oct 9, 2026, 4:10 PM AEST
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 21.01 million as of October 9, 2026. It is the 39,305th most valuable company in the world and the 1,081st biggest in Australia. Its market cap has increased by 0.08% in one year.
Market Cap
21.01M
Enterprise Value
18.62M
Revenue
4.73M
Global Rank
Country Rank
#1,081 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 21.01M, a decrease of -16.27%. That is a compound annual growth rate of -1.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 21.01M | 15.76% |
| Dec 31, 2025 | 18.15M | -68.34% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 26.03M |
| NeuroScientific Biopharmaceuticals | 24.55M |
| Radiopharm Theranostics | 23.86M |
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 19.05M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |